Wristband vs. cuff: can a cuffless device match 24-Hour blood pressure monitoring?

NCT ID NCT07072689

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time

Summary

Researchers are testing whether the Hilo Band, a cuffless wrist device, can measure blood pressure as accurately as the standard 24-hour ambulatory monitor. The study enrolls 40 young adults aged 21 to 35, including those with normal, low, or high blood pressure. Participants wear both devices for up to three days, and researchers compare daytime and nighttime readings to see how closely the band matches the reference method.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hilo Band, a cuffless blood pressure device worn on the wrist
What this could lead to
If the band performs well, it could offer a comfortable, low-cost way to track blood pressure over full days and nights, making it easier to spot hidden hypertension in young adults.
What could go wrong
The study is small and single-centre, so results may not hold in broader or older groups. Cuffless devices can also be sensitive to movement and body position, which may affect accuracy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This is a single-centre non-interventional performance research project investigating the performance of Hilo band in two different study populations: population 1 and population 2. In population 1, we will recruit young participants between 21 and 35 years of age that come to our San Giovanni Hospital in Bellinzona with indication to receive a 24-hour BPM. On the other hand, in population 2, we will recruit healthy, voluntary individuals between 21 and 35 years of age.

Ages

21 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Population 2: * Informed Consent signed by the subject * 21-35 years of age * Functional internet phone connection * Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant Population 1: * Informed Consent signed by the subject * 21-35 years of age * Clinical indication for receiving a 24-hour blood pressure measurement * Functional internet phone connection * Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant Exclusion Criteria for both population 1 and 2: * Allergies to silicone * Atrial fibrillation * Subjects with arrhythmia * Patients suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL / min / 1.73 m2), untreated hyper-/ hypothyroidism, pheochromocytoma, or arteriovenous fistula * Interarm Systolic Blood Pressure (SBP) difference over 10% or Diastolic Blood Pressure (DBP) difference over 10% * Arm paralysis * Amputated upper limb * Arm trembling or shivering * Upper arm circumference \> 64 cm * Wrist circumference \> 22 cm * Exfoliative skin diseases and lymphoedema or damaged/injured skin at the wrist * Pregnant women * Individuals with lack of judgment/mental illness * Sleepwalking and severe insomnia * Pica disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ente Ospedaliero Cantonale

    RECRUITING

    Bellinzona, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.